All Posts: biomedical research
-
Clinical Trial for Men With Osteoporosis Now Open for Volunteers
MEDIA CONTACT:Karen Teberkm463@georgetown.edu WASHINGTON (June 4, 2019) — Enrollment in a clinical trial testing a new treatment for men with osteoporosis is now open at Georgetown University Medical Center. Osteoporosis is a systemic skeletal disease characterized by low bone mass and deterioration of bone tissue (brittle bones) that makes bones more fragile and likely to […]
Category: News Release
-
MedStar Health-Georgetown University Symposium Illustrates Emphasis on Community Care
(June 2, 2019) — Since its founding, Georgetown University Medical Center has committed itself to the principle of cura personalis, caring for the whole person. However, based on the recent MedStar Health—Georgetown University Research Symposium, cura communitas, or care for the whole community, may be an equally good fit. Each year, the joint research symposium […]
Category: GUMC Stories
-
Georgetown University Launches Clinical Trial for Lewy Body Dementia
MEDIA CONTACT:(for members of the press only) Karen Teberkm463@georgetown.edu PATIENT INFORMATION:Joy Arellanomja6@gunet.georgetown.edu WASHINGTON (May 30, 2019) — Georgetown University Medical Center announces the launch of the only known therapeutic (disease modifying) clinical trial for Lewy body dementia, a neurological disorder that affects a million people in the United States for which there are no approved […]
Category: News Release
-
Students Leave BGE Programs Inspired by Courses, Faculty and Opportunities
(May 19, 2019) — More than 550 students graduated from Biomedical Graduate Education (BGE) certificate, master’s and PhD programs over this past year, with many returning to the Hilltop to attend the Graduate School of Arts & Sciences commencement ceremony on May 17. Georgetown University Medical Center’s BGE supports the over 35 biomedical programs by […]
Category: GUMC Stories
-
For Many HIV+ Women, Daily Survival Takes Precedence Over Viral Suppression
MEDIA CONTACT:Karen Teberkm463@georgetown.edu WASHINGTON (May 17, 2019) — According to scientists who study women infected with HIV, statistics often paint an impressionist view of the lives of these women that misses the granular detail that tells the real story. The imprecise big picture is that most of this population is doing a good job at […]
Category: News Release
-
Zebrafish Research Strengthens Students’ Interest in STEM
(April 26, 2019) — Participating in high-impact studies, peering into a fluorescence microscope and tracking cancer cells in animal models are all things Eric Glasgow, PhD, never had an opportunity to do when he was in college, much less high school. “Even though I always knew I wanted to be a scientist, I was barely […]
Category: GUMC Stories
-
Students Share Projects at NHS-Organized Undergraduate Research Conference
Category: GUMC Stories
-
Personalized Medicine Clinical Trial Underway for Type of Incontinence Common in Women
MEDIA CONTACT:Karen Teberkm463@georgetown.edu WASHINGTON (April 2, 2019) — A novel clinical trial aims to reverse the cause of a common problem among older women — accidental urine leakage — by using a patient’s own muscle cells. The study, now underway in the Washington area, is for women with stress urinary incontinence. Stress urinary incontinence, or […]
Category: News Release
-
Georgetown-Led Study Leads to First FDA-Approved Drug in Decades to Improve Survival in Small Cell Lung Cancer
MEDIA CONTACT:Karen Teberkm463@georgetown.edu WASHINGTON (March 18, 2019) — The U.S. Food and Drug Administration’s approval today of atezolizumab (Tecentriq®, Genentech) in combination with chemotherapy (carboplatin and etoposide) for the initial treatment of extensive-stage small cell lung cancer (SCLC) marks the end of numerous failed attempts to improve survival for those with the deadly disease. “Atezolizumab, […]
Category: News Release
-
Researchers Decode How Cancer Drug Works in Brains of Parkinson’s Disease Patients
MEDIA CONTACT:Karen Teberkm463@georgetown.edu WASHINGTON (March 12, 2019) — Laboratory analysis from the first arm of a phase II clinical trial testing the use of nilotinib in patients with Parkinson’s disease demonstrates precisely how the agent increases levels of dopamine in the brains of study participants, says a research team at Georgetown University Medical Center. Symptoms […]
Category: News Release